Safety of thrombolysis during menstruation

Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-13 ⓘ

The paper evaluates the safety of administering thrombolytic therapy during menstruation, providing data on potential risks associated with this treatment timing.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Menstruation Nifedipine Nitrates Thrombolytic Therapy Female Humans Menstruation Myocardial Infarction Myocardial Infarction Nifedipine Nitrates Thrombolytic Therapy

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:59:07.256998+00:00
License: CC0 · commercial use OK